These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12821453)

  • 21. Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity.
    Kontoyiannis DP; Lewis RE; Lionakis MS; Albert ND; May GS; Raad II
    Diagn Microbiol Infect Dis; 2003 Oct; 47(2):415-9. PubMed ID: 14522515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin.
    Kucharíková S; Tournu H; Lagrou K; Van Dijck P; Bujdáková H
    J Med Microbiol; 2011 Sep; 60(Pt 9):1261-1269. PubMed ID: 21566087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species.
    Antachopoulos C; Meletiadis J; Sein T; Roilides E; Walsh TJ
    Antimicrob Agents Chemother; 2007 Mar; 51(3):881-7. PubMed ID: 17145783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2006 Mar; 44(3):760-3. PubMed ID: 16517851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro Synergistic Activity of Caspofungin Plus Polymyxin B Against Fluconazole-Resistant Candida glabrata.
    Adams EK; Ashcraft DS; Pankey GA
    Am J Med Sci; 2016 Mar; 351(3):265-70. PubMed ID: 26992255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The fungicidal activity and paradoxical effect of caspofungin against yeast. Influence of culture medium and incubation time].
    Cantón E; Pemán J; Romero M; Valentín A; Gobernado M
    Rev Esp Quimioter; 2007 Dec; 20(4):433-41. PubMed ID: 18563217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caspofungin activity against clinical isolates of fluconazole-resistant Candida.
    Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
    J Clin Microbiol; 2003 Dec; 41(12):5729-31. PubMed ID: 14662968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.
    Oliveira ER; Fothergill AW; Kirkpatrick WR; Coco BJ; Patterson TF; Redding SW
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3544-5. PubMed ID: 16048980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).
    Espinel-Ingroff A; Fothergill A; Fuller J; Johnson E; Pelaez T; Turnidge J
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2855-9. PubMed ID: 21422219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caspofungin Etest endpoint for Aspergillus isolates shows poor agreement with the reference minimum effective concentration.
    Fuller J; Schofield A; Jiwa S; Sand C; Jansen B; Rennie R
    J Clin Microbiol; 2010 Feb; 48(2):479-82. PubMed ID: 20007389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus.
    Manavathu EK; Alangaden GJ; Chandrasekar PH
    J Antimicrob Chemother; 2003 Jun; 51(6):1423-5. PubMed ID: 12716776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872).
    Bartizal K; Gill CJ; Abruzzo GK; Flattery AM; Kong L; Scott PM; Smith JG; Leighton CE; Bouffard A; Dropinski JF; Balkovec J
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2326-32. PubMed ID: 9371328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometry susceptibility testing for the antifungal caspofungin.
    Mitchell M; Hudspeth M; Wright A
    J Clin Microbiol; 2005 Jun; 43(6):2586-9. PubMed ID: 15956368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of the broth micro- and macro-dilution techniques for the determination of the in vitro susceptibility of Aspergillus fumigatus.
    Manavathu EK; Alangaden GJ; Lerner SA
    Can J Microbiol; 1996 Sep; 42(9):960-4. PubMed ID: 8864219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes.
    Posteraro B; Sanguinetti M; Fiori B; La Sorda M; Spanu T; Sanglard D; Fadda G
    J Antimicrob Chemother; 2006 Aug; 58(2):458-61. PubMed ID: 16757500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation.
    Odds FC; Vranckx L; Woestenborghs F
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2051-60. PubMed ID: 8540715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microcolony imaging of Aspergillus fumigatus treated with echinocandins reveals both fungistatic and fungicidal activities.
    Ingham CJ; Schneeberger PM
    PLoS One; 2012; 7(4):e35478. PubMed ID: 22536390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.
    Oakley KL; Moore CB; Denning DW
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2726-30. PubMed ID: 9756785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.
    Gehrt A; Peter J; Pizzo PA; Walsh TJ
    J Clin Microbiol; 1995 May; 33(5):1302-7. PubMed ID: 7615745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.